Allenex
Allenex AB is a life science company, develops, manufactures, markets, and sells products for transplantation of blood stem cells.
Launch date
Employees
Market cap
-
Enterprise valuation
€32m (Public information from Dec 2015)
Stockholms kommun Stockholm County (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | - | - |
| % growth | - | (4 %) | 240 % | (66 %) | - | - |
| EBITDA | (1.5m) | (1.3m) | (<1m) | (<1m) | (<1m) | - |
| % EBITDA margin | (499 %) | (442 %) | (15 %) | (201 %) | - | - |
| Profit | (1.7m) | (18.1m) | (3.5m) | (7.0m) | (<1m) | (<1m) |
| % profit margin | (581 %) | (6284 %) | (356 %) | (2106 %) | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
$35.0m Valuation: $35.0m | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Allenex
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.